Patent dilemma for India drugs firms


India introduced a new patent law in 2005, under which several multinational pharmaceutical firms have been denied protection for their medicines.

This has lead to a debate about whether regulations need to be stronger in order to encourage innovation - but where do Indian manufacturers stand on the matter?

Yogita Limaye reports from Mumbai.

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.